This web site uses cookies. Do you accept the use of external cookies? Yes No Know more x
Survey about achondroplasia
We have designed a questionnaire with the purpose to better know the population connected to achondroplasia.
The questionnaire is optional and anonymous. The data obtained will be used for statistical purposes and to better understand the natural history of achondroplasia. Please consider answering.
If you would like to take the survey later, you can click on the link at the top "Register at BA"

This is the largest and most diverse international meeting in the field of bone, mineral, and musculoskeletal research, gathering more than 2,500 participants from over 50 countries. The program will include around 100 educational sessions and nearly 1,000 poster presentations over four days, covering a wide range of advances in basic, translational, and clinical research.

Among the highlights is the ASBMR/RBDA Pre-Meeting Symposium on Rare Bone Diseases: From the Genome to the Lived Experience, scheduled for Thursday, September 4, 2025, also at the Seattle Convention Center. This symposium will explore how scientific discoveries connect with the lived experience of people with rare bone diseases, creating opportunities for dialogue between researchers, clinicians, and patient representatives.

Inês Alves — President of the Board of ANDO Portugal, founder of Beyond Achondroplasia, and member of the European Rare Bone Forum (ERBF) — played a key role in co-authoring the abstract, supporting its submission, and contributing to the preparation of a scientific poster to be presented by Catherine Nester (ERBF, Biomarin). The poster will explore the challenges faced in rare bone research and propose ways to overcome them, while ensuring that the voices and perspectives of people living with achondroplasia and other rare skeletal conditions are represented in this global scientific forum.


Site   Program   Register

To view this site you need Internet Explorer 8 (or a higher version)
or another internet browser.


Thank You.